CRP and neurodegenerative disease: While the associations with diabetes and aspirin are consistent with the lower level of CRP found in APOE-ε4 carriers, their effects are unexpected in that diabetes [32, 33] and high levels of CRP [34, 35] have been reported as associated with an elevated risk of neurodegenerative diseases.